40
Participants
Start Date
June 30, 2012
Primary Completion Date
May 31, 2014
Study Completion Date
May 31, 2014
Bupropion
Crossover design: Oral administration of 150 mg bupropion once daily for 2 weeks, followed by 300 mg bupropion once daily for subsequent 8 weeks, tapering: 150 mg bupropion once daily for 7 days
Placebo
Crossover design: Oral administration of placebo once daily for 2 weeks, followed by placebo once daily for subsequent 8 weeks, tapering: placebo once daily for 7 days
Neurologische Klinik der Ruhr-Universität Bochum, Bochum
Universitätsklinikum Ulm, Klinik für Neurologie, Ulm
University of Ulm
OTHER
Ruhr University of Bochum
OTHER
University Hospital Muenster
OTHER
Charite University, Berlin, Germany
OTHER